OrthAlign

OrthAlign

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $50M

Overview

OrthAlign is a commercial-stage private company specializing in handheld surgical navigation systems for total and partial knee and hip replacements. The company has carved out a strategic niche by targeting the high-growth ASC segment with its portable, cost-effective Lantern technology, which avoids the complexity and capital expense of large robotic systems. Led by a seasoned management team with deep experience in medtech commercialization and M&A, OrthAlign is expanding its platform's surgical indications and approach support. Its primary challenge is competing in a crowded orthopedic navigation and robotics market dominated by larger players with broader portfolios and greater sales resources.

OrthopedicsMusculoskeletal

Technology Platform

Handheld, computer-assisted surgical navigation platform (Lantern) for precise alignment in hip and knee arthroplasty. Designed as portable, single-use instrument technology that does not require pre-operative imaging or large capital equipment.

Funding History

4
Total raised:$50M
Debt$5M
Series C$20M
Series B$15M
Series A$10M

Opportunities

The rapid migration of joint replacement surgeries to ambulatory surgery centers (ASCs) creates a massive demand for cost-effective, portable precision technology.
OrthAlign's handheld model is ideally suited for this high-growth segment.
Additionally, increasing clinical focus on alignment accuracy and patient outcomes drives adoption of navigation over manual techniques, providing a tailwind for the entire category.

Risk Factors

Intense competition from large, well-funded orthopedic companies with broader robotic surgery systems that are now also targeting the ASC market.
As a smaller player, OrthAlign may face challenges in funding large-scale clinical studies and competing with extensive sales and training infrastructures.
Market concentration risk exists due to reliance on joint replacement procedures.

Competitive Landscape

OrthAlign competes in the orthopedic computer-assisted surgery and robotics market, which is dominated by large players like Stryker (Mako), Zimmer Biomet (Rosa), Johnson & Johnson (Velys), and Smith & Nephew. Its primary competitive differentiation is its handheld, low-capital cost model focused on alignment, as opposed to larger robotic systems that offer bone preparation but at a significantly higher cost and footprint.